Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ji Li's research investigates molecular mechanisms underlying atherosclerosis and related cardiovascular conditions. Recent work has focused on the role of specific compounds and genetic factors in modulating inflammatory processes within macrophages, a key cell type in the development of atherosclerosis. Studies have explored the anti-atherosclerotic effects of quercetin and luteolin, highlighting their mechanisms in inhibiting macrophage pyroptosis and ferroptosis through pathways involving KEAP1 and NRF2. Additionally, research has examined the influence of homocysteine on atherosclerosis via endoplasmic reticulum stress and calcium dysregulation, and the impact of geraniin mediated by the gut microbiota-TMAO pathway. Li's scholarship also extends to the genetic underpinnings of cardiovascular disease, with publications investigating clonal hematopoiesis-driver mutations in patients with ST-segment elevation myocardial infarction. This body of work contributes to understanding cellular and genetic contributions to cardiovascular disease pathology.
Metrics
- h-index: 19
- Publications: 90
- Citations: 1,311
Selected Publications
-
Comparative effectiveness of telehealth-delivered family and standard models of diabetes self-management education and support for persons with type 2 diabetes mellitus (2025)
-
Medically Tailored Grocery Delivery for Food Pantry Clients with Diabetes (2025)
-
Sensitivity of Fit Indices to Model Complexity and Misspecification in Exploratory Structural Equation Modeling (2025)
-
Corrigendum to “COVID-19 vaccine hesitancy and racial discrimination among US adults” [Pre. Med. Rep. 31 (2022) 102074] (2025)
-
Corrigendum to “Social processes, practical issues, and COVID-19 vaccination among hesitant adults” [Vaccine 41(35) (2023) 5150–5158]. (2025)
-
Corrigendum to “Pediatric HPV vaccination: Provider recommendations matter among hesitant parents” [Vaccine 42(25) (2025) 126166] (2025)
-
A Qualitative Study of Social Processes, HPV Vaccine Attitudes, and Vaccination Behavior Among Hesitant Adopter Parents (2025)
-
Comparing Frequentist and Bayesian Methods for Factorial Invariance with Latent Distribution Heterogeneity (2025)
-
Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates (2024)
-
Associations between Influenza Vaccination and Health Care Access among Adults in the United States (2023)
Collaboration Network
Top Collaborators
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Polyphenols from blue honeysuckle (Lonicera caerulea var. edulis) berry inhibit lipid accumulation in adipocytes by suppressing lipogenesis
Showing 5 of 10 shared publications
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Luteolin prevents THP-1 macrophage pyroptosis by suppressing ROS production via Nrf2 activation
Showing 5 of 9 shared publications
- Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures
- A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy
- Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures
- DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing
- Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
Showing 5 of 7 shared publications
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Plaque erosion risk and <i>JAK2</i> V617F variant
- Targeting KEAP1/NRF2 interaction with oleuropein ameliorates atherosclerosis by inhibiting macrophage ferroptosis
Showing 5 of 7 shared publications
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Plaque erosion risk and <i>JAK2</i> V617F variant
- Targeting KEAP1/NRF2 interaction with oleuropein ameliorates atherosclerosis by inhibiting macrophage ferroptosis
Showing 5 of 7 shared publications
- Associations between Influenza Vaccination and Health Care Access among Adults in the United States
- Pediatric HPV vaccination: Provider recommendations matter among hesitant parents
- Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates
- A Qualitative Study of Social Processes, HPV Vaccine Attitudes, and Vaccination Behavior Among Hesitant Adopter Parents
- Corrigendum to “Pediatric HPV vaccination: Provider recommendations matter among hesitant parents” [Vaccine 42(25) (2025) 126166]
Showing 5 of 7 shared publications
- Associations between Influenza Vaccination and Health Care Access among Adults in the United States
- Pediatric HPV vaccination: Provider recommendations matter among hesitant parents
- Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates
- A Qualitative Study of Social Processes, HPV Vaccine Attitudes, and Vaccination Behavior Among Hesitant Adopter Parents
- Corrigendum to “Pediatric HPV vaccination: Provider recommendations matter among hesitant parents” [Vaccine 42(25) (2025) 126166]
Showing 5 of 7 shared publications
- Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures
- A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy
- DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing
- Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
- iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell–cell crosstalk network
Showing 5 of 6 shared publications
- Associations between Influenza Vaccination and Health Care Access among Adults in the United States
- Pediatric HPV vaccination: Provider recommendations matter among hesitant parents
- Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates
- Corrigendum to “Pediatric HPV vaccination: Provider recommendations matter among hesitant parents” [Vaccine 42(25) (2025) 126166]
- Corrigendum to “Social processes, practical issues, and COVID-19 vaccination among hesitant adults” [Vaccine 41(35) (2023) 5150–5158].
Showing 5 of 6 shared publications
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Plaque erosion risk and <i>JAK2</i> V617F variant
- Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Plaque erosion risk and <i>JAK2</i> V617F variant
- Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
- Plaque erosion risk and <i>JAK2</i> V617F variant
- Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
- Corrigendum to “MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction” [Redox Biol. 69 (2024) 102987]
- A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy
- Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures
- Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
- iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell–cell crosstalk network
- Drug Target Set Enrichment Analysis (DTSEA): A Network-Based Approach for Drug Repurposing to COVID-19
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
- Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
- Corrigendum to “MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction” [Redox Biol. 69 (2024) 102987]
- A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
- MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
- Targeting KEAP1/NRF2 interaction with oleuropein ameliorates atherosclerosis by inhibiting macrophage ferroptosis
- Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
- Corrigendum to “MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction” [Redox Biol. 69 (2024) 102987]
Similar Researchers
Based on overlapping research topics